Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Adcytherix has raised $122.4M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Adcytherix's investors include Bpifrance, RA Capital Management, Andera Partners, Kurma Partners, Pontifax.
Adcytherix is headquartered in Marseille, France.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Adcytherix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adcytherix — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/adcytherix. Accessed August 24, 2026.
VCBacked. (2025). Adcytherix — Funding & Investors. Retrieved August 24, 2026, from https://www.vcbacked.co/company/adcytherix
{{cite web |title=Adcytherix — Funding & Investors |url=https://www.vcbacked.co/company/adcytherix |website=VCBacked |access-date=August 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated